CHICAGO, April 23, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced its full-year 2018 financial results for the year ended December 31, 2018. 2018 Highlights: - Revenue improved 23.6% to $37 million from $30 million in 2017 - Gross profit increase 23.1% to $2.4 million from $1.96 million in 2017 - Operating expenses decreased by 46.7% year over year. - Repaid the remaining balance of its convertible notes, totaling $5.5 million. - Completed the acquisition of Cosmofarm Ltd., www.cosmofarm.gr, a fully licensed pharmaceutical wholesale company, in December of 2018 which features a fully automated supply chain and integrated robotic fulfillment center powered by ROWA. - Entered the Nutraceutical market with its own premium brand of food supplements - Sky Premium Life. Grigorios Siokas, Chief Executive Officer commented, “Our focus in 2018 included increasing our core distribution business, formally launching our Sky Premium Life food supplement brand, expanding our direct to pharmacy reach, and vertically integrating into our supply chain. Looking to 2019 we will be focusing on building our Sky Premium Life food supplement brand along with expanding our product offerings.”
Photo
David E. Gutierrez
Head of PR, IR
and Corporate Development

Join our mailing list to stay up to date.

Cosmos-logo